Jason O'Byrne
CHIEF FINANCIAL OFFICER; EVP & Chief Financial Officer · 4 filings · Latest: Sep 1, 2026
Olema Pharmaceuticals, Inc.
Vir Biotechnology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VIR | O'Byrne Jason | — | Sep 17, 2026 | Proposed Sale | $11.00 | 19,357 | $212.9K | — | |
VIR | O'Byrne Jason | — | Sep 9, 2026 | Proposed Sale | $11.13 | 28,333 | $315.2K | — | |
VIR | O'Byrne Jason | — | Aug 25, 2026 | Proposed Sale | $10.48 | 23,148 | $242.6K | — | |
VIR | O'Byrne Jason | — | Aug 24, 2026 | Proposed Sale | $9.90 | 14,352 | $142.1K | — | |
VIR | O'Byrne Jason | — | Aug 21, 2026 | Proposed Sale | $9.81 | 25,000 | $245.3K | — | |
VIR | Jason O'Byrne | EVP & Chief Financial Officer | Feb 24, 2026 | Sale | $9.53 | 1,634 | $15.6K | 162,615 | |
VIR | Jason O'Byrne | EVP & Chief Financial Officer | Feb 23, 2026 | Sale | $7.45 | 2,089 | $15.6K | 164,249 | |
VIR | O'Byrne Jason | — | Feb 24, 2026 | Proposed Sale | $9.53 | 1,634 | $15.6K | — | |
VIR | O'Byrne Jason | — | Feb 23, 2026 | Proposed Sale | $7.45 | 2,089 | $15.6K | — | |
VIR | O'Byrne Jason | — | Nov 17, 2025 | Proposed Sale | $5.56 | 6,799 | $37.8K | — |